Using an ancient tool for igniting and propagating immune tolerance: IDO as an inducer and amplifier of regulatory T cell functions

Current Medicinal Chemistry

Volumn 18, Issue 15, 2011, Pages 2215-2221

  Fallarino, F ^a   Grohmann, U ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

Author keywords

Amino acid starvation; Dendritic Cells; IDO; Kynurenines; Regulatory T cells; Tryptophan catabolism

Indexed keywords

3 HYDROXYANTHRANILIC ACID; INDOLEAMINE 2,3 DIOXYGENASE; KYNURENINASE; KYNURENINE; RECOMBINANT GAMMA INTERFERON; TRANILAST; TRANSCRIPTION FACTOR FOXP3; TRYPTOPHAN;

ARTICLE; BIOCHEMISTRY; CATABOLISM; CD4+ CD25+ T LYMPHOCYTE; CELL COMPARTMENTALIZATION; CELL LINEAGE; CELL TYPE; DENDRITIC CELL; ENZYME ACTIVITY; ENZYME DEGRADATION; HELPER CELL; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATORY CELL; LYMPHOCYTE FUNCTION; MICROENVIRONMENT; NONHUMAN; PLASTICITY; PROTEIN EXPRESSION; PROTEIN MALNUTRITION; REGULATORY T LYMPHOCYTE; TH17 CELL; THYMUS;

EID: 79957959848     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/092986711795656027     Document Type: Article

References (94)

1. Goodnow, C.C.; Sprent, J.; Fazekas de St Groth, B.; Vinuesa, C.G. Cellular and genetic mechanisms of self tolerance and autoimmunity. Nature, 2005, 435(7042), 590-597. (Pubitemid 40825498)
2. Mathis, D.; Benoist, C. Back to central tolerance. Immunity, 2004, 20(5), 509-516. (Pubitemid 38638121)
3. Fontenot, J.D.; Rasmussen, J.P.; Williams, L.M.; Dooley, J.L.; Farr, A.G.; Rudensky, A.Y. Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity, 2005, 22(3), 329-341. (Pubitemid 40387475)
4. Sakaguchi, S. Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses. Annu. Rev. Immunol., 2004, 22, 531-562. (Pubitemid 38680433)
5. Danke, N.A.; Koelle, D.M.; Yee, C.; Beheray, S.; Kwok, W.W. Autoreactive T cells in healthy individuals. J. Immunol., 2004, 172(10), 5967-5972. (Pubitemid 38621196)
6. Bluestone, J.A.; Abbas, A.K. Natural versus adaptive regulatory T cells. Nat. Rev. Immunol., 2003, 3(3), 253-257. (Pubitemid 37323210)
7. Zhou, X.; Bailey-Bucktrout, S.L.; Jeker, L.T.; Penaranda, C.; Martinez- Llordella, M.; Ashby, M.; Nakayama, M.; Rosenthal, W.; Bluestone, J.A. Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo. Nat. Immunol., 2009, 10(9), 1000-1007.
8. Gavin, M.A.; Rasmussen, J.P.; Fontenot, J.D.; Vasta, V.; Manganiello, V.C.; Beavo, J.A.; Rudensky, A.Y. Foxp3-dependent programme of regulatory Tcell differentiation. Nature, 2007, 445(7129), 771-775. (Pubitemid 46279714)
9. Hori, S.; Nomura, T.; Sakaguchi, S. Control of regulatory T cell development by the transcription factor Foxp3. Science, 2003, 299(5609), 1057-1061. (Pubitemid 36222930)
10. Roncarolo, M.G.; Gregori, S.; Battaglia, M.; Bacchetta, R.; Fleischhauer, K.; Levings, M.K. Interleukin-10-secreting type 1 regulatory T cells in rodents and humans. Immunol. Rev., 2006, 212, 28-50. (Pubitemid 44116698)
11. Faria, A.M.; Weiner, H.L. Oral tolerance: therapeutic implications for autoimmune diseases. Clin. Dev. Immunol., 2006, 13(2-4), 143-157. (Pubitemid 44950033)
12. Chang, C.C.; Ciubotariu, R.; Manavalan, J.S.; Yuan, J.; Colovai, A.I.; Piazza, F.; Lederman, S.; Colonna, M.; Cortesini, R.; Dalla-Favera, R.; Suciu-Foca, N. Tolerization of dendritic cells by T(S) cells: the crucial role of inhibitory receptors ILT3 and ILT4. Nat. Immunol., 2002, 3(3), 237-243. (Pubitemid 34218114)
13. Zhang, Z.X.; Yang, L.; Young, K.J.; DuTemple, B.; Zhang, L. Identification of a previously unknown antigen-specific regulatory T cell and its mechanism of suppression. Nat. Med., 2000, 6(7), 782-789. (Pubitemid 30469427)
14. Kronenberg, M. Toward an understanding of NKT cell biology: progress and paradoxes. Annu. Rev. Immunol., 2005, 23, 877-900. (Pubitemid 40563188)
15. Hayday, A.; Tigelaar, R. Immunoregulation in the tissues by gammadelta T cells. Nat. Rev. Immunol., 2003, 3(3), 233-242.
16. Pulendran, B.; Tang, H.; Denning, T.L. Division of labor, plasticity, and crosstalk between dendritic cell subsets. Curr. Opin. Immunol., 2008, 20(1), 61-67.
17. Mahnke, K.; Knop, J.; Enk, A.H. Induction of tolerogenic DCs: 'you are what you eat'. Trends. Immunol., 2003, 24(12), 646-651. (Pubitemid 37485914)
18. Goldschneider, I.; Cone, R.E. A central role for peripheral dendritic cells in the induction of acquired thymic tolerance. Trends. Immunol., 2003, 24(2), 77-81. (Pubitemid 36120643)
19. Gad, M.; Claesson, M.H.; Pedersen, A.E. Dendritic cells in peripheral tolerance and immunity. APMIS, 2003, 111(7-8), 766-775. (Pubitemid 37130023)
20. Tan, J.K.; O'Neill, H.C. Maturation requirements for dendritic cells in T cell stimulation leading to tolerance versus immunity. J. Leukoc. Biol., 2005, 78(2), 319-324. (Pubitemid 41061304)
21. Lanzavecchia, A.; Sallusto, F. The instructive role of dendritic cells on T cell responses: lineages, plasticity and kinetics. Curr. Opin. Immunol., 2001, 13(3), 291-298. (Pubitemid 32537700)
22. Ueno, H.; Klechevsky, E.; Morita, R.; Aspord, C.; Cao, T.; Matsui, T.; Di Pucchio, T.; Connolly, J.; Fay, J.W.; Pascual, V.; Palucka, A.K.; Banchereau, J. Dendritic cell subsets in health and disease. Immunol. Rev., 2007, 219, 118-142. (Pubitemid 47393528)
23. Medzhitov, R. Recognition of microorganisms and activation of the immune response. Nature, 2007, 449(7164), 819-826. (Pubitemid 47598622)
24. Li, L.; Liu, S.; Zhang, T.; Pan, W.; Yang, X.; Cao, X. Splenic stromal microenvironment negatively regulates virus-activated plasmacytoid dendritic cells through TGF-beta. J. Immunol., 2008, 180(5), 2951-2956.
25. Fallarino, F.; Grohmann, U.; Hwang, K.W.; Orabona, C.; Vacca, C.; Bianchi, R.; Belladonna, M.L.; Fioretti, M.C.; Alegre, M.L.; Puccetti, P. Modulation of tryptophan catabolism by regulatory T cells. Nat. Immunol., 2003, 4(12), 1206-1212. (Pubitemid 37547898)
26. Fallarino, F.; Grohmann, U.; You, S.; McGrath, B.C.; Cavener, D.R.; Vacca, C.; Orabona, C.; Bianchi, R.; Belladonna, M.L.; Volpi, C.; Santamaria, P.; Fioretti, M.C.; Puccetti, P. The combined effects of tryptophan starvation and tryptophan catabolites down-regulate T cell receptor zeta-chain and induce a regulatory phenotype in naive T cells. J. Immunol., 2006, 176(11), 6752-6761. (Pubitemid 43787857)
27. Waldmann, H.; Adams, E.; Fairchild, P.; Cobbold, S. Infectious tolerance and the long-term acceptance of transplanted tissue. Immunol. Rev., 2006, 212, 301-313. (Pubitemid 44116716)
28. Belladonna, M.L.; Orabona, C.; Grohmann, U.; Puccetti, P. TGF-beta and kynurenines as the key to infectious tolerance. Trends. Mol. Med., 2009, 15(2), 41-49.
29. Grohmann, U.; Volpi, C.; Fallarino, F.; Bozza, S.; Bianchi, R.; Vacca, C.; Orabona, C.; Belladonna, M.L.; Ayroldi, E.; Nocentini, G.; Boon, L.; Bistoni, F.; Fioretti, M.C.; Romani, L.; Riccardi, C.; Puccetti, P. Reverse signaling through GITR ligand enables dexamethasone to activate IDO in allergy. Nat. Med., 2007, 13(5), 579-586. (Pubitemid 46828479)
30. Romani, L.; Fallarino, F.; De Luca, A.; Montagnoli, C.; D'Angelo, C.; Zelante, T.; Vacca, C.; Bistoni, F.; Fioretti, M.C.; Grohmann, U.; Segal, B.H.; Puccetti, P. Defective tryptophan catabolism underlies inflammation in mouse chronic granulomatous disease. Nature, 2008, 451(7175), 211-215.
31. Mellor, A.L.; Munn, D.H. IDO expression by dendritic cells: tolerance and tryptophan catabolism. Nat. Rev. Immunol., 2004, 4(10), 762-774. (Pubitemid 39336293)
32. Grohmann, U.; Fallarino, F.; Puccetti, P. Tolerance, DCs and tryptophan: much ado about IDO. Trends. Immunol., 2003, 24(5), 242-248. (Pubitemid 36555962)
33. Sugimoto, H.; Oda, S.; Otsuki, T.; Hino, T.; Yoshida, T.; Shiro, Y. Crystal structure of human indoleamine 2,3-dioxygenase: catalytic mechanism of O2 incorporation by a heme-containing dioxygenase. Proc. Natl. Acad. Sci. U. S. A., 2006, 103(8), 2611-2616.
34. Fallarino, F.; Luca, G.; Calvitti, M.; Mancuso, F.; Nastruzzi, C.; Fioretti, M.C.; Grohmann, U.; Becchetti, E.; Burgevin, A.; Kratzer, R.; van Endert, P.; Boon, L.; Puccetti, P.; Calafiore, R. Therapy of experimental type 1 diabetes by isolated Sertoli cell xenografts alone. J. Exp. Med., 2009, 206(11), 2511-2526.
35. Matysiak, M.; Stasiolek, M.; Orlowski, W.; Jurewicz, A.; Janczar, S.; Raine, C.S.; Selmaj, K. Stem cells ameliorate EAE via an indoleamine 2,3- dioxygenase (IDO) mechanism. J. Neuroimmunol., 2008, 193(1-2), 12-23.
36. Haniffa, M.A.; Wang, X.N.; Holtick, U.; Rae, M.; Isaacs, J.D.; Dickinson, A.M.; Hilkens, C.M.; Collin, M.P. Adult human fibroblasts are potent immunoregulatory cells and functionally equivalent to mesenchymal stem cells. J. Immunol., 2007, 179(3), 1595-1604.
37. Jones, B.J.; Brooke, G.; Atkinson, K.; McTaggart, S.J. Immunosuppression by placental indoleamine 2,3-dioxygenase: a role for mesenchymal stem cells. Placenta, 2007, 28(11-12), 1174-1181. (Pubitemid 47570911)
38. Belladonna, M.L.; Volpi, C.; Bianchi, R.; Vacca, C.; Orabona, C.; Pallotta, M.T.; Boon, L.; Gizzi, S.; Fioretti, M.C.; Grohmann, U.; Puccetti, P. Cutting edge: Autocrine TGF-beta sustains default tolerogenesis by IDO-competent dendritic cells. J. Immunol., 2008, 181(8), 5194-5198.
39. Ueno, A.; Cho, S.; Cheng, L.; Wang, J.; Hou, S.; Nakano, H.; Santamaria, P.; Yang, Y. Transient upregulation of indoleamine 2,3-dioxygenase in dendritic cells by human chorionic gonadotropin downregulates autoimmune diabetes. Diabetes, 2007, 56(6), 1686-1693. (Pubitemid 46842605)
40. Zhu, W.H.; Lu, C.Z.; Huang, Y.M.; Link, H.; Xiao, B.G. A putative mechanism on remission of multiple sclerosis during pregnancy: estrogeninduced indoleamine 2,3-dioxygenase by dendritic cells. Mult. Scler., 2007, 13(1), 33-40. (Pubitemid 46152759)
41. von Bergwelt-Baildon, M.S.; Popov, A.; Saric, T.; Chemnitz, J.; Classen, S.; Stoffel, M.S.; Fiore, F.; Roth, U.; Beyer, M.; Debey, S.; Wickenhauser, C.; Hanisch, F.G.; Schultze, J.L. CD25 and indoleamine 2,3-dioxygenase are upregulated by prostaglandin E2 and expressed by tumor-associated dendritic cells in vivo: additional mechanisms of T-cell inhibition. Blood, 2006, 108(1), 228-237. (Pubitemid 43990633)
42. Puccetti, P.; Grohmann, U. IDO and regulatory T cells: a role for reverse signalling and non-canonical NF-kappaB activation. Nat. Rev. Immunol., 2007, 7(10), 817-823. (Pubitemid 47480306)
43. Fallarino, F.; Volpi, C.; Zelante, T.; Vacca, C.; Calvitti, M.; Fioretti, M.C.; Puccetti, P.; Romani, L.; Grohmann, U. IDO mediates TLR9-driven protection from experimental autoimmune diabetes. J. Immunol., 2009, 183(10), 6303-6312.
44. Grohmann, U.; Orabona, C.; Fallarino, F.; Vacca, C.; Calcinaro, F.; Falorni, A.; Candeloro, P.; Belladonna, M.L.; Bianchi, R.; Fioretti, M.C.; Puccetti, P. CTLA-4-Ig regulates tryptophan catabolism in vivo. Nat. Immunol., 2002, 3(11), 1097-1101. (Pubitemid 35363664)
45. Orabona, C.; Grohmann, U.; Belladonna, M.L.; Fallarino, F.; Vacca, C.; Bianchi, R.; Bozza, S.; Volpi, C.; Salomon, B.L.; Fioretti, M.C.; Romani, L.; Puccetti, P. CD28 induces immunostimulatory signals in dendritic cells via CD80 and CD86. Nat. Immunol., 2004, 5(11), 1134-1142. (Pubitemid 39549627)
46. Orabona, C.; Belladonna, M.L.; Vacca, C.; Bianchi, R.; Fallarino, F.; Volpi, C.; Gizzi, S.; Fioretti, M.C.; Grohmann, U.; Puccetti, P. Cutting edge: silencing suppressor of cytokine signaling 3 expression in dendritic cells turns CD28-Ig from immune adjuvant to suppressant. J. Immunol., 2005, 174(11), 6582-6586. (Pubitemid 40705617)
47. Orabona, C.; Pallotta, M.T.; Volpi, C.; Fallarino, F.; Vacca, C.; Bianchi, R.; Belladonna, M.L.; Fioretti, M.C.; Grohmann, U.; Puccetti, P. SOCS3 drives proteasomal degradation of indoleamine 2,3-dioxygenase (IDO) and antagonizes IDO-dependent tolerogenesis. Proc. Natl. Acad. Sci. U. S. A., 2008, 105(52), 20828-20833.
48. Niwa, Y.; Kanda, H.; Shikauchi, Y.; Saiura, A.; Matsubara, K.; Kitagawa, T.; Yamamoto, J.; Kubo, T.; Yoshikawa, H. Methylation silencing of SOCS-3 promotes cell growth and migration by enhancing JAK/STAT and FAK signalings in human hepatocellular carcinoma. Oncogene, 2005, 24(42), 6406-6417. (Pubitemid 41486474)
49. Cui, Q.; Jiang, W.; Wang, Y.; Lv, C.; Luo, J.; Zhang, W.; Lin, F.; Yin, Y.; Cai, R.; Wei, P.; Qian, C. Transfer of suppressor of cytokine signaling 3 by an oncolytic adenovirus induces potential antitumor activities in hepatocellular carcinoma. Hepatology, 2008, 47(1), 105-112. (Pubitemid 351171047)
50. Munn, D.H.; Zhou, M.; Attwood, J.T.; Bondarev, I.; Conway, S.J.; Marshall, B.; Brown, C.; Mellor, A.L. Prevention of allogeneic fetal rejection by tryptophan catabolism. Science, 1998, 281(5380), 1191-1193. (Pubitemid 28406294)
51. Platten, M.; Ho, P.P.; Youssef, S.; Fontoura, P.; Garren, H.; Hur, E.M.; Gupta, R.; Lee, L.Y.; Kidd, B.A.; Robinson, W.H.; Sobel, R.A.; Selley, M.L.; Steinman, L. Treatment of autoimmune neuroinflammation with a synthetic tryptophan metabolite. Science, 2005, 310(5749), 850-855. (Pubitemid 41567343)
52. Gurtner, G.J.; Newberry, R.D.; Schloemann, S.R.; McDonald, K.G.; Stenson, W.F. Inhibition of indoleamine 2,3-dioxygenase augments trinitrobenzene sulfonic acid colitis in mice. Gastroenterology, 2003, 125(6), 1762-1773. (Pubitemid 37500441)
53. Seo, S.K.; Choi, J.H.; Kim, Y.H.; Kang, W.J.; Park, H.Y.; Suh, J.H.; Choi, B.K.; Vinay, D.S.; Kwon, B.S. 4-1BB-mediated immunotherapy of rheumatoid arthritis. Nat. Med., 2004, 10(10), 1088-1094. (Pubitemid 39424870)
54. Popov, A.; Abdullah, Z.; Wickenhauser, C.; Saric, T.; Driesen, J.; Hanisch, F.G.; Domann, E.; Raven, E.L.; Dehus, O.; Hermann, C.; Eggle, D.; Debey, S.; Chakraborty, T.; Kronke, M.; Utermohlen, O.; Schultze, J.L. Indoleamine 2,3-dioxygenase-expressing dendritic cells form suppurative granulomas following Listeria monocytogenes infection. J. Clin. Invest., 2006, 116(12), 3160-3170. (Pubitemid 44878630)
55. Hayashi, T.; Beck, L.; Rossetto, C.; Gong, X.; Takikawa, O.; Takabayashi, K.; Broide, D.H.; Carson, D.A.; Raz, E. Inhibition of experimental asthma by indoleamine 2,3-dioxygenase. J. Clin. Invest., 2004, 114(2), 270-279. (Pubitemid 39071632)
56. Muller, A.J.; DuHadaway, J.B.; Donover, P.S.; Sutanto-Ward, E.; Prendergast, G.C. Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy. Nat. Med., 2005, 11(3), 312-319. (Pubitemid 40460560)
57. Uyttenhove, C.; Pilotte, L.; Theate, I.; Stroobant, V.; Colau, D.; Parmentier, N.; Boon, T.; Van den Eynde, B.J. Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3- dioxygenase. Nat. Med., 2003, 9(10), 1269-1274. (Pubitemid 37279849)
58. Munn, D.H.; Sharma, M.D.; Hou, D.; Baban, B.; Lee, J.R.; Antonia, S.J.; Messina, J.L.; Chandler, P.; Koni, P.A.; Mellor, A.L. Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumordraining lymph nodes. J. Clin. Invest., 2004, 114(2), 280-290. (Pubitemid 39071633)
59. Curti, A.; Trabanelli, S.; Salvestrini, V.; Baccarani, M.; Lemoli, R.M. The role of indoleamine 2,3-dioxygenase in the induction of immune tolerance: focus on hematology. Blood, 2009, 113(11), 2394-2401.
60. Boasso, A.; Herbeuval, J.P.; Hardy, A.W.; Anderson, S.A.; Dolan, M.J.; Fuchs, D.; Shearer, G.M. HIV inhibits CD4+ T-cell proliferation by inducing indoleamine 2,3-dioxygenase in plasmacytoid dendritic cells. Blood, 2007, 109(8), 3351-3359. (Pubitemid 46572523)
61. Blander, J.M.; Amsen, D. Immunology. Amino acid addiction. Science, 2009, 324(5932), 1282-1283.
62. Sharma, M.D.; Hou, D.Y.; Liu, Y.; Koni, P.A.; Metz, R.; Chandler, P.; Mellor, A.L.; He, Y.; Munn, D.H. Indoleamine 2,3-dioxygenase controls conversion of Foxp3+ Tregs to TH17-like cells in tumor-draining lymph nodes. Blood, 2009, 113(24), 6102-6111.
63. Munn, D.H.; Sharma, M.D.; Baban, B.; Harding, H.P.; Zhang, Y.; Ron, D.; Mellor, A.L. GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase. Immunity, 2005, 22(5), 633-642. (Pubitemid 40719198)
64. Cobbold, S.P.; Adams, E.; Farquhar, C.A.; Nolan, K.F.; Howie, D.; Lui, K.O.; Fairchild, P.J.; Mellor, A.L.; Ron, D.; Waldmann, H. Infectious tolerance via the consumption of essential amino acids and mTOR signaling. Proc. Natl. Acad. Sci. U. S. A., 2009, 106(29), 12055-12060.
65. Fallarino, F.; Grohmann, U.; Vacca, C.; Bianchi, R.; Orabona, C.; Spreca, A.; Fioretti, M.C.; Puccetti, P. T cell apoptosis by tryptophan catabolism. Cell Death Differ., 2002, 9(10), 1069-1077.
66. Hayashi, T.; Mo, J.H.; Gong, X.; Rossetto, C.; Jang, A.; Beck, L.; Elliott, G.I.; Kufareva, I.; Abagyan, R.; Broide, D.H.; Lee, J.; Raz, E. 3- Hydroxyanthranilic acid inhibits PDK1 activation and suppresses experimental asthma by inducing T cell apoptosis. Proc. Natl. Acad. Sci. U. S. A., 2007, 104(47), 18619-18624. (Pubitemid 350210746)
67. Tang, Q.; Bluestone, J.A. The Foxp3+ regulatory T cell: a jack of all trades, master of regulation. Nat. Immunol., 2008, 9(3), 239-244. (Pubitemid 351267321)
68. Shevach, E.M. Mechanisms of foxp3+ T regulatory cell-mediated suppression. Immunity, 2009, 30(5), 636-645.
69. Garin, M.I.; Chu, C.C.; Golshayan, D.; Cernuda-Morollon, E.; Wait, R.; Lechler, R.I. Galectin-1: a key effector of regulation mediated by CD4+CD25+ T cells. Blood, 2007, 109(5), 2058-2065. (Pubitemid 46348206)
70. Pandiyan, P.; Zheng, L.; Ishihara, S.; Reed, J.; Lenardo, M.J. CD4+CD25+Foxp3+ regulatory T cells induce cytokine deprivationmediated apoptosis of effector CD4+ T cells. Nat. Immunol., 2007, 8(12), 1353-1362. (Pubitemid 350131172)
71. Collison, L.W.; Workman, C.J.; Kuo, T.T.; Boyd, K.; Wang, Y.; Vignali, K.M.; Cross, R.; Sehy, D.; Blumberg, R.S.; Vignali, D.A. The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature, 2007, 450(7169), 566-569. (Pubitemid 350190247)
72. Grossman, W.J.; Verbsky, J.W.; Barchet, W.; Colonna, M.; Atkinson, J.P.; Ley, T.J. Human T regulatory cells can use the perforin pathway to cause autologous target cell death. Immunity, 2004, 21(4), 589-601. (Pubitemid 39370513)
73. Qin, H.Y.; Mukherjee, R.; Lee-Chan, E.; Ewen, C.; Bleackley, R.C.; Singh, B. A novel mechanism of regulatory T cell-mediated down-regulation of autoimmunity. Int. Immunol., 2006, 18(7), 1001-1015. (Pubitemid 43923420)
74. Uhlig, H.H.; Coombes, J.; Mottet, C.; Izcue, A.; Thompson, C.; Fanger, A.; Tannapfel, A.; Fontenot, J.D.; Ramsdell, F.; Powrie, F. Characterization of Foxp3+CD4+CD25+ and IL-10-secreting CD4+CD25+ T cells during cure of colitis. J. Immunol., 2006, 177(9), 5852-5860.
75. Liang, B.; Workman, C.; Lee, J.; Chew, C.; Dale, B.M.; Colonna, L.; Flores, M.; Li, N.; Schweighoffer, E.; Greenberg, S.; Tybulewicz, V.; Vignali, D.; Clynes, R. Regulatory T cells inhibit dendritic cells by lymphocyte activation gene-3 engagement of MHC class II. J. Immunol., 2008, 180(9), 5916-5926.
76. Borsellino, G.; Kleinewietfeld, M.; Di Mitri, D.; Sternjak, A.; Diamantini, A.; Giometto, R.; Hopner, S.; Centonze, D.; Bernardi, G.; Dell'Acqua, M.L.; Rossini, P.M.; Battistini, L.; Rotzschke, O.; Falk, K. Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression. Blood, 2007, 110(4), 1225-1232. (Pubitemid 47281420)
77. Shalev, I.; Liu, H.; Koscik, C.; Bartczak, A.; Javadi, M.; Wong, K.M.; Maknojia, A.; He, W.; Liu, M.F.; Diao, J.; Winter, E.; Manuel, J.; McCarthy, D.; Cattral, M.; Gommerman, J.; Clark, D.A.; Phillips, M.J.; Gorczynski, R.R.; Zhang, L.; Downey, G.; Grant, D.; Cybulsky, M.I.; Levy, G. Targeted deletion of fgl2 leads to impaired regulatory T cell activity and development of autoimmune glomerulonephritis. J. Immunol., 2008, 180(1), 249-260.
78. Sarris, M.; Andersen, K.G.; Randow, F.; Mayr, L.; Betz, A.G. Neuropilin-1 expression on regulatory T cells enhances their interactions with dendritic cells during antigen recognition. Immunity, 2008, 28(3), 402-413.
79. Puccetti, P.; Fallarino, F. Generation of T cell regulatory activity by plasmacytoid dendritic cells and tryptophan catabolism. Blood Cells Mol. Dis., 2008, 40(1), 101-105. (Pubitemid 350192308)
80. Curti, A.; Pandolfi, S.; Valzasina, B.; Aluigi, M.; Isidori, A.; Ferri, E.; Salvestrini, V.; Bonanno, G.; Rutella, S.; Durelli, I.; Horenstein, A.L.; Fiore, F.; Massaia, M.; Colombo, M.P.; Baccarani, M.; Lemoli, R.M. Modulation of tryptophan catabolism by human leukemic cells results in the conversion of CD25- into CD25+ T regulatory cells. Blood, 2007, 109(7), 2871-2877. (Pubitemid 46482083)
81. Chen, W.; Jin, W.; Hardegen, N.; Lei, K.J.; Li, L.; Marinos, N.; McGrady, G.; Wahl, S.M. Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J. Exp. Med., 2003, 198(12), 1875-1886. (Pubitemid 38032120)
82. Travis, M.A.; Reizis, B.; Melton, A.C.; Masteller, E.; Tang, Q.; Proctor, J.M.; Wang, Y.; Bernstein, X.; Huang, X.; Reichardt, L.F.; Bluestone, J.A.; Sheppard, D. Loss of integrin alpha(v)beta8 on dendritic cells causes autoimmunity and colitis in mice. Nature, 2007, 449(7160), 361-365. (Pubitemid 47443473)
83. Paust, S.; Cantor, H. Regulatory T cells and autoimmune disease. Immunol. Rev., 2005, 204, 195-207. (Pubitemid 40460503)
84. Konrad, L.; Munir Keilani, M.; Cordes, A.; Volck-Badouin, E.; Laible, L.; Albrecht, M.; Renneberg, H.; Aumuller, G. Rat Sertoli cells express epithelial but also mesenchymal genes after immortalization with SV40. Biochim. Biophys. Acta, 2005, 1722(1), 6-14. (Pubitemid 40222399)
85. Zhang, Q.; Shi, S.; Liu, Y.; Uyanne, J.; Shi, Y.; Le, A.D. Mesenchymal stem cells derived from human gingiva are capable of immunomodulatory functions and ameliorate inflammation-related tissue destruction in experimental colitis. J. Immunol., 2009, 183(12), 7787-7798.
86. Tipnis, S.; Viswanathan, C.; Majumdar, A.S. Immunosuppressive properties of human umbilical cord-derived mesenchymal stem cells: role of B7-H1 and IDO. Immunol. Cell Biol., 2010, 88(8), 795-806.
87. Zheng, Y.; Chaudhry, A.; Kas, A.; deRoos, P.; Kim, J.M.; Chu, T.T.; Corcoran, L.; Treuting, P.; Klein, U.; Rudensky, A.Y. Regulatory T-cell suppressor program co-opts transcription factor IRF4 to control T(H)2 responses. Nature, 2009, 458(7236), 351-356.
88. Voo, K.S.; Wang, Y.H.; Santori, F.R.; Boggiano, C.; Arima, K.; Bover, L.; Hanabuchi, S.; Khalili, J.; Marinova, E.; Zheng, B.; Littman, D.R.; Liu, Y.J. Identification of IL-17-producing FOXP3+ regulatory T cells in humans. Proc. Natl. Acad. Sci. U. S. A., 2009, 106(12), 4793-4798.
89. Ziegler, S.F. FOXP3: not just for regulatory T cells anymore. Eur. J. Immunol., 2007, 37(1), 21-23. (Pubitemid 46128782)
90. Floess, S.; Freyer, J.; Siewert, C.; Baron, U.; Olek, S.; Polansky, J.; Schlawe, K.; Chang, H.D.; Bopp, T.; Schmitt, E.; Klein-Hessling, S.; Serfling, E.; Hamann, A.; Huehn, J. Epigenetic control of the foxp3 locus in regulatory T cells. PLoS Biol., 2007, 5(2), e38.
91. Xu, L.; Kitani, A.; Fuss, I.; Strober, W. Cutting edge: regulatory T cells induce CD4+CD25-Foxp3- T cells or are self-induced to become Th17 cells in the absence of exogenous TGF-beta. J. Immunol., 2007, 178(11), 6725-6729. (Pubitemid 46847395)
92. Yang, X.O.; Nurieva, R.; Martinez, G.J.; Kang, H.S.; Chung, Y.; Pappu, B.P.; Shah, B.; Chang, S.H.; Schluns, K.S.; Watowich, S.S.; Feng, X.H.; Jetten, A.M.; Dong, C. Molecular antagonism and plasticity of regulatory and inflammatory T cell programs. Immunity, 2008, 29(1), 44-56.
93. Komatsu, N.; Mariotti-Ferrandiz, M.E.; Wang, Y.; Malissen, B.; Waldmann, H.; Hori, S. Heterogeneity of natural Foxp3+ T cells: a committed regulatory T-cell lineage and an uncommitted minor population retaining plasticity. Proc. Natl. Acad. Sci. U. S. A., 2009, 106(6), 1903-1908.
94. De Luca, A.; Montagnoli, C.; Zelante, T.; Bonifazi, P.; Bozza, S.; Moretti, S.; D'Angelo, C.; Vacca, C.; Boon, L.; Bistoni, F.; Puccetti, P.; Fallarino, F.; Romani, L. Functional yet balanced reactivity to Candida albicans requires TRIF, MyD88, and IDO-dependent inhibition of Rorc. J. Immunol., 2007, 179(9), 5999-6008.